Grief, Trauma, and PTSD: 6 Evidence-Based Ways to Distinguish Normal Grief from Traumatic Stress — and Find Your Path Through Both

This article examines the clinical, neurobiological, and philosophical dimensions of grief, Prolonged Grief Disorder (PGD), and PTSD following loss, providing a framework for distinguishing between these three conditions and an evidence-based overview of their respective pathways. The clinical framework draws on the DSM-5-TR 2022 inclusion of Prolonged Grief Disorder (PGD) as a distinct diagnosis, requiring acute grief lasting more than 12 months with distress and disability; George Bonanno's Columbia University resilience research documenting the majority of bereaved as more resilient than expected; and the neurobiological distinction between grief and PTSD as documented in fMRI and volumetric neuroimaging research. The neuroscience draws on 2025 Sage Journals review of grief neurobiology (amygdala, hippocampus, prefrontal cortex alterations), PTSD fMRI evidence (amygdala hyperactivation, hippocampal reduction, mPFC suppression), and the HPA axis differences between grief and trauma responses. Evidence-based interventions reviewed include EMDR therapy (WHO and APA recommended as first-line PTSD treatment), Cognitive Behavioural Therapy for PGD, and Complicated Grief Treatment (CGT). The Bhagavad Gita's treatment of Arjuna's grief — the foundational text of the Gita being Krishna's response to grief-induced paralysis — is examined alongside the Vedic concept of Shoka and Vairagya as the ancient Indian philosophical framework for loss.